Search Results - "Kailajärvi, M"

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment by KEMPPAINEN, N. M, AALTO, S, PARKKOLA, R, RINNE, J. O, WILSON, I. A, NAGREN, K, HELIN, S, BRÜCK, A, OIKONEN, V, KAILAJÄRVI, M, SCHEININ, M, VIITANEN, M

“…Patients with mild cognitive impairment (MCI) have increased risk to develop Alzheimer disease (AD). In AD increased brain amyloid burden has been demonstrated…”
Get full text

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease by KEMPPAINEN, N. M, AALTO, S, PARKKOLA, R, RINNE, J. O, WILSON, I. A, NAGREN, K, HELIN, S, BRÜCK, A, OIKONEN, V, KAILAJÄRVI, M, SCHEININ, M, VIITANEN, M

“…PET studies with N-methyl-[(11)C]2-(4':-methylaminophenyl)-6-hydroxybenzothiazole ([(11)C]PIB) have revealed an increased tracer uptake in several brain…”
Get full text

Reminders of Drug Effects on Laboratory Test Results by Kailajarvi, Marita, Takala, Timo, Gronroos, Paula, Tryding, Nils, Viikari, Jorma, Irjala, Kerttu, Forsstrom, Jari

“…Drug effects on laboratory test results are difficult to take into account without an online decision support system. In this study, drug effects on hormone…”
Get full text

Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients by Leinonen, V., Rinne, J. O., Virtanen, K. A., Eskola, O., Rummukainen, J., Huttunen, J., von und zu Fraunberg, M., Nerg, O., Koivisto, A. M., Rinne, J., Jääskeläinen, J. E., Buckley, C., Smith, A., Jones, P. A., Sherwin, P., Farrar, G., McLain, R., Kailajärvi, M., Heurling, K., Grachev, I. D.

“…Background and purpose This study determined the correlation between uptake of the amyloid positron emission tomography (PET) imaging agent [18F]flutemetamol…”
Get full text

Night-time bioavailability of levodopa/carbidopa/entacapone is higher compared to controlled-release levodopa/carbidopa by Kuoppamäki, M, Sauramo, A, Korpela, K, Vahteristo, M, Kailajärvi, M, Lehtinen, T, Ellmén, J

“…Controlled-release levodopa/carbidopa (CR-LC) is often used to provide prolonged control of night-time motor symptoms in patients with Parkinson's disease…”
Get full text

Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids by Kailajärvi, M, Ahokoski, O, Virtanen, A, Salminen, E, Irjala, K

“…Tamoxifen is widely used as an adjuvant treatment for breast cancer. To correctly interpret laboratory test results during tamoxifen treatment, clinicians…”
Get more information

Early effects of 5-fluorouracil, epirubicin and cyclophosphamide therapy on common laboratory tests by Kailajärvi, M, Ahokoski, O, Virtanen, A, Salminen, E, Irjala, K

“…Combination chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC) is now used for adjuvant therapy of breast cancer. The effects of FEC on…”
Get more information

Assessment of MAO‐B Occupancy in the Brain With PET and [11C]‐L‐Deprenyl‐D2: A Dose‐Finding Study With a Novel MAO‐B Inhibitor, EVT 301 by Hirvonen, J, Kailajärvi, M, Haltia, T, Koskimies, S, Någren, K, Virsu, P, Oikonen, V, Sipilä, H, Ruokoniemi, P, Virtanen, K, Scheinin, M, Rinne, JO

“…Inhibition of monoamine oxidase type B (MAO‐B) activity in the brain is a putative strategy for the treatment of Alzheimer's disease (AD). We performed a…”
Get full text

Alterations in laboratory test results during adjuvant breast cancer treatment by Kailajärvi, M, Ahokoski, O, Virtanen, A, Salminen, E, Irjala, K

“…An increasing number of women is treated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil therapy for breast cancer. The effects of the…”
Get more information

Frequency and clinical outcome of potentially harmful Drug metabolic interactions in patients hospitalized on internal and pulmonary medicine wards : Focus on warfarin and cisapride by LAINE, Kari, FORSSTRÖM, Jari, GRÖNROOS, Paula, IRJALA, Kerttu, KAILAJÄRVI, Marita, SCHEININ, Mika

“…Drug metabolic interactions present potential risks in patient care, but their frequency and relative importance as a clinical problem remains unclear. To…”
Get full text

[18F]-Flutemetamol PET Amyloid Imaging and Cortical Biopsy Histopathology in Normal Pressure Hydrocephalus: Pooled Analysis of Four Studies (S34.001) by Wolk, D., Rinne, J., Wong, D., Leinonen, V., Arnold, S., Buckley, C., Smith, A., McLain, R., Sherwin, P., Farrar, G., Kailajarvi, M., Grachev, I.

“…Abstract only…”
Get full text

[18F]-Flutemetamol PET Amyloid Imaging and Cortical Biopsy Histopathology in Normal Pressure Hydrocephalus: Pooled Analysis of Four Studies (IN3-1.009) by Wolk, D., Rinne, J., Wong, D., Leinonen, V., Arnold, S., Buckley, C., Smith, A., McLain, R., Sherwin, P., Farrar, G., Kailajarvi, M., Grachev, I.

“…Abstract only…”
Get full text

Serum cholesterol, HDL cholesterol and triglycerides during adjuvant CMF therapy in premenopausal breast cancer patients by Kailajárvi, M., Ahokoski, O., Virtanen, A., Salminen, E., Irjala, K.

Get full text

Support to clinician's decision making--automatic comments about drug effects on laboratory results by Takala, T I, Forsström, J J, Grönroos, P, Kailajärvi, M, Irjala, K

Get full text